Nyxoah (NASDAQ:NYXH) Announces Earnings Results

Nyxoah (NASDAQ:NYXH) posted its quarterly earnings data on Thursday. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03), Zacks reports. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%.

Nyxoah Stock Up 4.6 %

NYXH stock opened at $10.51 on Friday. Nyxoah has a twelve month low of $6.76 and a twelve month high of $20.00. The company has a market cap of $357.97 million, a PE ratio of -5.62 and a beta of 1.42. The business’s 50-day simple moving average is $10.29 and its 200 day simple moving average is $9.18. The company has a quick ratio of 4.95, a current ratio of 5.28 and a debt-to-equity ratio of 0.21.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. HC Wainwright reaffirmed a “buy” rating and set a $17.00 price objective on shares of Nyxoah in a research note on Friday, December 13th. Stifel Nicolaus cut their price objective on shares of Nyxoah from $16.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.